Related Experiment Video
Updated: May 19, 2026
09:02
Characterization of Intra-Cartilage Transport Properties of Cationic Peptide Carriers
Published on: August 10, 2020
[Modified release intra-articular drug delivery systems].
Andrea Szabó1, Barnabas Szabó, Emese Balogh
1DocMorris Apotheke Neustadt, Mainz, Németország, Kreyssigstr. 19. D-55118.
Acta Pharmaceutica Hungarica
|August 9, 2012
Summary
Intraarticular drug delivery aims to reduce injection frequency and infection risk by using advanced carrier systems. These systems, including nanoparticles and liposomes, enable sustained drug release and combination therapies for improved outcomes.
Area of Science:
- Biomedical Engineering
- Pharmaceutics
- Drug Delivery Systems
Context:
- Intraarticular formulations offer localized drug delivery, minimizing systemic side effects.
- Current limitations include infection risk during injections and the need for reduced administration frequency.
- Existing treatments primarily involve hyaluronic acid or glucocorticoids, with limited sustained-release options.
Purpose:
- To review novel carrier systems for intraarticular drug delivery.
- To highlight scientific advancements in sustained drug release technologies.
- To discuss the potential for combination therapies and reduced injection burdens.
Summary:
- Advanced carrier systems such as micro/nanoparticles, liposomes, and hydrogels offer sustained drug release for intraarticular injections.
- Physically activated systems (thermoresponsive, magnetically modulated) are being explored for enhanced drug delivery.
- These technologies aim to prolong therapeutic effects, reduce injection frequency, and mitigate infection risks.
Impact:
- Enables long-term drug exposure from a single intraarticular injection.
- Facilitates the development of combination therapies for complex joint conditions.
- Reduces patient discomfort and healthcare burden associated with frequent injections.
Related Concept Videos
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:22Modified-Release Drug Delivery Systems: Drug Release Characteristics
Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...